The utilization of ELISA in early detection of cancer

Xiaoyang Zhou

doi:10.62051/a40a7s47

Authors

Xiaoyang Zhou

DOI:

https://doi.org/10.62051/a40a7s47

Keywords:

ELISA; Cancer; Detection.

Abstract

The early detection of cancer is crucial in improving treatment success rates and survival rates. The primary focus of this research is the application of enzyme-linked immunosorbent assay (ELISA) in early cancer detection, as well as the measurement methods of cancer biomarkers. It can provide an overview of the currently used cancer biomarkers and their application in ELISA. Furthermore, this research will utilize the ELISA technique to determine whether a specific substance can serve as a cancer biomarker, with a particular emphasis on its application in early cancer detection. Through a comprehensive analysis of relevant research, this research elucidates the significance of ELISA in the measurement of cancer biomarkers and its potential as a robust cancer screening tool. Finally, this research will highlight the future directions of research, focusing on the implementation of ELISA technology in detecting and identifying a wider range of cancer biomarkers for achieving more accurate early cancer diagnosis.

Downloads

Download data is not yet available.

References

Peng P, Liu C, Li Z, et al. 2022 TrAC Trends in Analytical Chemistry152 116605.

Zhou, Y. Preliminary exploration and development of a novel tumor marker ELISA kit based on REGγ. East China Normal University, 2022. DOI:10.27149/d.cnki.ghdsu.2020.002195.

Chen D, Yang X, Huang L, et al. 2013 Journal of Investigative Medicine 61 (8) 1192 - 1196.

Zhou L, Yao L, Zhang Q, et al. 2020 Cellular & Molecular Immunology 17 (11) 1136 - 1147.

Rouleau C, Curiel M, Weber W, et al. 2008 Clinical cancer research 14 (22) 7223 - 7236.

Huber M A, Kraut N, Schweifer N, et al. 2006 Journal of cutaneous pathology 33 (2) 145 - 155.

Davies G, Cunnick G H, Mansel R E, et al. 2004 Clinical & experimental metastasis 21 31 - 37.

Zhang, W. Establishment of the Endosialin/TEM1 (CD248) ELISA detection method. Southern Medical University, 2017.

Dou, R. Detection of peripheral blood MUC1 protein levels in adenocarcinoma patients using double antibody sandwich ELISA method. Jilin University, 2010.

von Mensdorff-Pouilly S, Snijdewint F G M, Verstraeten A A, et al. 2000 The International Journal of Biological Markers 15 (4) 343 - 356.

Luo W, Dong L, Chen F, et al. 2022 Frontiers in Immunology 13 928438.

Saracoglu U, Guven O, Durak I. 2005 Oral diseases 11 (5) 323 - 325.